Tai Sandi See, Chief Development Officer at Lexeo Therapeutics, Inc. (LXEO), sold 382 shares at $4.67 ($2K) on 2025-08-18, disclosed to the SEC on 2025-08-20.
Open-market sale of $2k LXEO by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LXEO | SELL | 2025-05-20 | $1K | — | Filing → |
| LXEO | SELL | 2025-02-21 | $7K | — | Filing → |